168 related articles for article (PubMed ID: 26136217)
1. The Blood-Brain Barrier Challenge for the Treatment of Brain Cancer, Secondary Brain Metastases, and Neurological Diseases.
Weidle UH; Niewöhner J; Tiefenthaler G
Cancer Genomics Proteomics; 2015; 12(4):167-77. PubMed ID: 26136217
[TBL] [Abstract][Full Text] [Related]
2. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
Pardridge WM; Boado RJ
Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573
[TBL] [Abstract][Full Text] [Related]
3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
4. Molecular Trojan horses for blood-brain barrier drug delivery.
Pardridge WM
Curr Opin Pharmacol; 2006 Oct; 6(5):494-500. PubMed ID: 16839816
[TBL] [Abstract][Full Text] [Related]
5. Improving drug delivery to primary and metastatic brain tumors: strategies to overcome the blood-brain barrier.
Parrish KE; Sarkaria JN; Elmquist WF
Clin Pharmacol Ther; 2015 Apr; 97(4):336-46. PubMed ID: 25669487
[TBL] [Abstract][Full Text] [Related]
6. Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology.
Pardridge WM
BioDrugs; 2017 Dec; 31(6):503-519. PubMed ID: 29067674
[TBL] [Abstract][Full Text] [Related]
7. Emerging insights into the molecular biology of brain metastases.
Chen G; Davies MA
Biochem Pharmacol; 2012 Feb; 83(3):305-14. PubMed ID: 21946085
[TBL] [Abstract][Full Text] [Related]
8. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
Arvanitis CD; Ferraro GB; Jain RK
Nat Rev Cancer; 2020 Jan; 20(1):26-41. PubMed ID: 31601988
[TBL] [Abstract][Full Text] [Related]
9. Drug-loaded bubbles with matched focused ultrasound excitation for concurrent blood-brain barrier opening and brain-tumor drug delivery.
Fan CH; Ting CY; Chang YC; Wei KC; Liu HL; Yeh CK
Acta Biomater; 2015 Mar; 15():89-101. PubMed ID: 25575854
[TBL] [Abstract][Full Text] [Related]
10. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
[TBL] [Abstract][Full Text] [Related]
11. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.
Pardridge WM
Bioconjug Chem; 2008 Jul; 19(7):1327-38. PubMed ID: 18547095
[TBL] [Abstract][Full Text] [Related]
12. Dissection of the Process of Brain Metastasis Reveals Targets and Mechanisms for Molecular-based Intervention.
Weidle UH; Birzele F; Kollmorgen G; Rüger R
Cancer Genomics Proteomics; 2016; 13(4):245-58. PubMed ID: 27365375
[TBL] [Abstract][Full Text] [Related]
13. Development of a Bifunctional Aptamer Targeting the Transferrin Receptor and Epithelial Cell Adhesion Molecule (EpCAM) for the Treatment of Brain Cancer Metastases.
Macdonald J; Henri J; Goodman L; Xiang D; Duan W; Shigdar S
ACS Chem Neurosci; 2017 Apr; 8(4):777-784. PubMed ID: 28010059
[TBL] [Abstract][Full Text] [Related]
14. The blood-brain barrier: structure, function and therapeutic approaches to cross it.
Tajes M; Ramos-Fernández E; Weng-Jiang X; Bosch-Morató M; Guivernau B; Eraso-Pichot A; Salvador B; Fernàndez-Busquets X; Roquer J; Muñoz FJ
Mol Membr Biol; 2014 Aug; 31(5):152-67. PubMed ID: 25046533
[TBL] [Abstract][Full Text] [Related]
15. The role of the organ microenvironment in brain metastasis.
Fidler IJ
Semin Cancer Biol; 2011 Apr; 21(2):107-12. PubMed ID: 21167939
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of protein and gene medicines through the blood-brain barrier.
Pardridge WM
Clin Pharmacol Ther; 2015 Apr; 97(4):347-61. PubMed ID: 25669455
[TBL] [Abstract][Full Text] [Related]
17. New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.
Doolittle ND; Abrey LE; Bleyer WA; Brem S; Davis TP; Dore-Duffy P; Drewes LR; Hall WA; Hoffman JM; Korfel A; Martuza R; Muldoon LL; Peereboom D; Peterson DR; Rabkin SD; Smith Q; Stevens GH; Neuwelt EA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):421-8. PubMed ID: 15701824
[TBL] [Abstract][Full Text] [Related]
18. Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horse.
Boado RJ; Hui EK; Lu JZ; Pardridge WM
J Pharmacol Exp Ther; 2010 Jun; 333(3):961-9. PubMed ID: 20233799
[TBL] [Abstract][Full Text] [Related]
19. Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting.
Doolittle ND; Peereboom DM; Christoforidis GA; Hall WA; Palmieri D; Brock PR; Campbell KC; Dickey DT; Muldoon LL; O'Neill BP; Peterson DR; Pollock B; Soussain C; Smith Q; Tyson RM; Neuwelt EA
J Neurooncol; 2007 Jan; 81(1):81-91. PubMed ID: 16858513
[TBL] [Abstract][Full Text] [Related]
20. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier.
Yan H; Wang L; Wang J; Weng X; Lei H; Wang X; Jiang L; Zhu J; Lu W; Wei X; Li C
ACS Nano; 2012 Jan; 6(1):410-20. PubMed ID: 22148835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
